Fragmented implementation and interpretation of the General Data Protection Regulation 2016/679 (GDPR) of the European Union (EU) at a local level are posing obstacles to cancer research, especially in the pandemic era when collaboration and data sharing are vital for moving science forward.
On Friday 21 May 2021 (13:00-15:30 CEST) key stakeholders (among which BBMRI-ERIC represented by Michaela Th. Mayrhofer, Head of ELSI Services and Research) in public policy and oncology will discuss major implications of the GDPR on clinical research and how to overcome existing challenges at a freely-accessible webinar organised by ESMO in association with the MEPs Against Cancer (MAC) Interest Group at the European Parliament.